Joanne Wuensch
Stock Analyst at Citi
(2.73)
# 2,884
Out of 4,974 analysts
1251
Total ratings
51.3%
Success rate
0.9%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Reiterated: Hold | $80 → $60 | $53.27 | +12.63% | 57 | Sep 11, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $125 | $102.03 | +22.51% | 88 | Sep 10, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $61 → $57 | $43.87 | +29.93% | 80 | Sep 10, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $85.74 | +28.29% | 82 | Sep 10, 2026 | |
| MDT Medtronic | Reiterated: Buy | $110 | $93.75 | +17.33% | 85 | Sep 10, 2026 | |
| SYK Stryker | Reiterated: Buy | $399 → $360 | $281.50 | +27.89% | 60 | Sep 10, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $26 | $22.01 | +18.13% | 6 | Sep 2, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $204 → $208 | $185.92 | +11.88% | 40 | Aug 14, 2026 | |
| DXCM DexCom | Reiterated: Buy | $88 → $105 | $86.45 | +21.46% | 65 | Aug 14, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $188 → $225 | $171.68 | +31.06% | 45 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $8 | $8.11 | -1.36% | 28 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $16.28 | +47.42% | 46 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $23.71 | +18.09% | 61 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $17.23 | +21.88% | 18 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $71.48 | +28.71% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 | $64.07 | +17.06% | 27 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 | $106.20 | -13.37% | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $15.69 | +21.10% | 30 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $111.92 | +40.29% | 58 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $377.16 | +32.57% | 36 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 | $267.20 | +11.53% | 63 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $139.24 | +7.73% | 45 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $99 | $98.41 | +0.60% | 63 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $417.09 | +12.69% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $412 | $365.00 | +12.88% | 1 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $96 | $126.21 | -23.94% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $350 | $318.43 | +9.91% | 43 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.15 | $1.91 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 54.69 → CHF 56.33 | CHF 55.18 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $229.44 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $27.55 | n/a | 2 | Sep 26, 2016 |
The Cooper Companies
Sep 11, 2026
Reiterated: Hold
Price Target: $80 → $60
Current: $53.27
Upside: +12.63%
Abbott Laboratories
Sep 10, 2026
Reiterated: Buy
Price Target: $125
Current: $102.03
Upside: +22.51%
Boston Scientific
Sep 10, 2026
Reiterated: Buy
Price Target: $61 → $57
Current: $43.87
Upside: +29.93%
Edwards Lifesciences
Sep 10, 2026
Reiterated: Buy
Price Target: $110
Current: $85.74
Upside: +28.29%
Medtronic
Sep 10, 2026
Reiterated: Buy
Price Target: $110
Current: $93.75
Upside: +17.33%
Stryker
Sep 10, 2026
Reiterated: Buy
Price Target: $399 → $360
Current: $281.50
Upside: +27.89%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $26
Current: $22.01
Upside: +18.13%
Becton, Dickinson and Company
Aug 14, 2026
Reiterated: Buy
Price Target: $204 → $208
Current: $185.92
Upside: +11.88%
DexCom
Aug 14, 2026
Reiterated: Buy
Price Target: $88 → $105
Current: $86.45
Upside: +21.46%
Glaukos
Aug 14, 2026
Reiterated: Buy
Price Target: $188 → $225
Current: $171.68
Upside: +31.06%
Aug 14, 2026
Reiterated: Hold
Price Target: $6 → $8
Current: $8.11
Upside: -1.36%
Aug 14, 2026
Reiterated: Hold
Price Target: $21 → $24
Current: $16.28
Upside: +47.42%
Aug 13, 2026
Reiterated: Hold
Price Target: $28
Current: $23.71
Upside: +18.09%
Aug 13, 2026
Reiterated: Buy
Price Target: $21
Current: $17.23
Upside: +21.88%
Aug 13, 2026
Upgraded: Buy
Price Target: $92
Current: $71.48
Upside: +28.71%
Aug 13, 2026
Reiterated: Hold
Price Target: $75
Current: $64.07
Upside: +17.06%
Aug 13, 2026
Reiterated: Hold
Price Target: $92
Current: $106.20
Upside: -13.37%
Aug 13, 2026
Reiterated: Hold
Price Target: $19
Current: $15.69
Upside: +21.10%
Aug 13, 2026
Reiterated: Buy
Price Target: $157
Current: $111.92
Upside: +40.29%
Aug 13, 2026
Reiterated: Buy
Price Target: $500
Current: $377.16
Upside: +32.57%
Aug 13, 2026
Reiterated: Buy
Price Target: $298
Current: $267.20
Upside: +11.53%
Aug 13, 2026
Reiterated: Hold
Price Target: $150
Current: $139.24
Upside: +7.73%
Aug 13, 2026
Reiterated: Hold
Price Target: $99
Current: $98.41
Upside: +0.60%
Aug 10, 2026
Reiterated: Buy
Price Target: $470
Current: $417.09
Upside: +12.69%
Aug 3, 2026
Reiterated: Buy
Price Target: $412
Current: $365.00
Upside: +12.88%
Jul 8, 2026
Reiterated: Hold
Price Target: $92 → $96
Current: $126.21
Upside: -23.94%
Jul 8, 2026
Reiterated: Hold
Price Target: $350
Current: $318.43
Upside: +9.91%
May 23, 2025
Reiterated: Hold
Price Target: $4.15
Current: $1.91
Upside: n/a
Nov 16, 2022
Reiterated: Hold
Price Target: CHF 54.69 → CHF 56.33
Current: CHF 55.18
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $229.44
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $27.55
Upside: n/a